Interestingly, in a cohort of male breast cancer patients cyclin D1 overexpression was predicative of better patient survival, while high levels of cyclin A and B expression increase the risk for breast cancer related death by 2–3 fold [57]. Here, CCND1 is linked to breast cancer.